Zoar files Form F-4 for Impact Biomedical business combination
DSS said Zoar filed a preliminary Form F-4 with the SEC for Impact Biomedical’s proposed business combination with Zoar, subject to SEC review and other closing conditions.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.